Mechanism of Fatty Acid-induced Impairment of Glucose-simulated Insulin Secretion - Effect of Buphenyl

NCT00533559 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Diabetes
Insulin Resistance

Interventions

DRUG: sodium phenylbutyrate
DRUG: Placebo

Sponsor

University Health Network, Toronto